Bajaj Finserv Healthcare Fund

ThematicDirect and Regular plans, Growth and IDCW options

Data as on 30-10-2026

Bajaj Finserv Healthcare Fund is a Thematic fund run by Bajaj Finserv Mutual Fund. On 30-09-2026, it managed ₹405 Cr of investors' money. In the year to 30-10-2026, its Direct plan returned 19.0% and its Regular plan returned 17.0%. Its benchmark, BSE Healthcare TRI, returned 12.4% over the same year.

NAV (Direct plan): ₹11.88; ▲ 1.40%30-10-2026
NAV (Regular plan): ₹11.52; ▲ 1.39%30-10-2026
Expense ratio: 0.90%Direct2.59%Regular; 0.90%; A year
Riskometer: Very High; Set by the fund house
1 year return: 19.0%Direct17.0%Regular; 19.0%; Total

Bajaj Finserv Healthcare Fund NAV Today

NAV on 30-10-2026: Direct Plan Growth ₹11.88 (up 1.40% that day); Regular Plan Growth ₹11.52 (up 1.39% that day).

This fund (Direct plan)

₹11.883

Bajaj Finserv Healthcare Fund Returns vs BSE Healthcare TRI

Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.

Trailing returns
Period	1M	3M	6M	1Y	3Y	5Y	10Y
This fund (Direct)	+0.73%	+1.91%	+18.19%	+19.00%	--	--	--
This fund (Regular)	+0.59%	+1.48%	+17.19%	+17.02%	--	--	--
BSE Healthcare TRI	+0.24%	−0.99%	+12.80%	+12.37%	+23.01%	+15.61%	+12.48%
Thematic average	−2.09%	−4.52%	+0.86%	−1.22%	--	--	--
Best in Thematic	+11.54%	+11.27%	+22.16%	+75.71%	--	--	--
Worst in Thematic	−16.05%	−11.74%	−13.97%	−22.44%	--	--	--
Rank in Thematic	22/235	18/232	4/232	6/215	--	--	--

Category rows compare the Direct plans of 235 Thematic funds. Rank 1 is the highest return.

Bajaj Finserv Healthcare Fund Year-wise Returns

Return of each calendar year
Year	Direct	Regular	BSE Healthcare TRI
2026to date	+21.23%	+19.55%	+15.08%
2025	−2.94%	−4.58%	−2.72%

Bajaj Finserv Healthcare Fund Rolling Returns

The return of every holding period in the fund's history, not only the one that ends today

Rolling returns

Each point is the yearly return of one 1-year holding period, plotted on the day it ended. There are 205 periods, one for each trading day from 30-12-2025 to 30-10-2026.

−10%0%10%20%30%

Jan 2025
to
Jan 2026Mar 2025
to
Mar 2026May 2025
to
May 2026Jun 2025
to
Jun 2026Aug 2025
to
Aug 2026Oct 2025
to
Oct 2026

Bajaj Finserv Healthcare Fund (Direct)BSE Healthcare TRI

Every holding period at a glance

Period	Periods	Median	Lowest	Highest	With a loss	Benchmark median	Beat benchmark
1 year	205	12.6%	−4.2%	27.1%	11%	10.7%	80%

Lumpsum: the yearly rate (CAGR) from the NAV on a period's first day to the NAV on its last. SIP: the XIRR of the monthly instalments and their value on the last day. "With a loss" counts the periods that ended below the money put in. "Beat benchmark" counts the periods in which the fund did better than BSE Healthcare TRI over the same days. Past returns do not promise future returns.

Bajaj Finserv Healthcare Fund Risk

How much it swings, and the falls an investor had to sit through

Risk and return

Measure	Bajaj Finserv Healthcare Fund (Direct)This fund	BSE Healthcare TRI
Return (CAGR)	+19.00%	+12.37%
Standard deviation	13.24%	13.56%
Sharpe ratio	1.04	0.53
Sortino ratio	1.53	0.77
Maximum drawdown	−10.9% (23-10-2026)	−9.9% (23-10-2026)
Beta	0.91	1.00
Alpha	+7.28%	0.00%

From daily NAVs, 30-10-2025 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta: 1 moves with the benchmark, below 1 moves less. Alpha: return beyond what its beta explains, a year.

Measure	Bajaj Finserv Healthcare Fund (Direct)This fund	BSE Healthcare TRI
Return (CAGR)	+9.39%	+6.50%
Standard deviation	13.58%	14.79%
Sharpe ratio	0.28	0.06
Sortino ratio	0.39	0.09
Maximum drawdown	−15.7% (28-02-2025)	−16.2% (28-02-2025)
Beta	0.87	1.00
Alpha	+3.02%	0.00%

From daily NAVs, 30-12-2024 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta: 1 moves with the benchmark, below 1 moves less. Alpha: return beyond what its beta explains, a year.

Drawdowns

How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.

−20%−15%−10%−5%0%

20252026

Bajaj Finserv Healthcare Fund (Direct)BSE Healthcare TRI

	Worst fall	High before it	Bottom	Back at the high	Time to climb back	Below its high today
Bajaj Finserv Healthcare Fund (Direct)	−15.7%	02-01-2025	28-02-2025	17-11-2025	9 months	−4.4%
BSE Healthcare TRI	−16.2%	02-01-2025	28-02-2025	29-07-2025	5 months	−3.8%

From the Direct plan's daily NAV since 30-12-2024, adjusted for unit splits, and BSE Healthcare TRI over the same days. "Time to climb back" runs from the bottom to the first day back at the old high.

Bajaj Finserv Healthcare Fund vs Other Thematic Funds

The five Thematic funds with the best three year return, and this fund. Direct plans.

Fund name	Rank	AUM (Cr)	Exp. ratio	1Y return	3Y return	3Y alpha	3Y beta	3Y Sharpe	3Y Sortino
Nippon India Taiwan Equity Fund	1/133	1,147	1.08%	+75.71%	+54.78%	--	--	1.38	2.03	Compare
HDFC Defence Fund	2/133	11,493	0.90%	+13.79%	+34.76%	−0.18%	0.83	1.12	1.54	Compare
HDFC Pharma and Healthcare Fund	3/133	3,501	1.05%	+23.12%	+30.53%	+8.23%	0.96	1.74	2.49	Compare
SBI Healthcare Opportunities Fund	4/133	5,870	1.01%	+17.12%	+24.60%	+3.61%	0.88	1.42	2.03	Compare
Aditya Birla Sun Life International Equity Fund	5/133	352	2.00%	+13.97%	+24.46%	--	--	1.49	2.16	Compare
Bajaj Finserv Healthcare Fund	6/215	405	0.90%	+19.00%	--	--	--	--	--

AUM is each fund's size at the end of its last reported month, from its own portfolio file. We calculate the risk ratios from daily NAVs over the last three years. The risk-free return is what NSE's overnight rate index earned over the same years. Alpha and beta compare each fund with its own benchmark's TRI. "--" means we have no figure: for alpha and beta, no daily series for that benchmark.

Bajaj Finserv Healthcare Fund Expense Ratio and Costs

What each plan charges a year, in force from 01-09-2026

Plan	Base expense ratio	Brokerage	Transaction costs	Levies and GST	Total expense ratio	Thematic median	Cost rank (1 = cheapest)
Direct	0.66%	0.04%	0.00%	0.20%	0.90%	1.18%	27/235
Regular	2.09%	0.04%	0.00%	0.46%	2.59%	2.41%	160/235

The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, the cost of executing trades, and statutory levies with GST. From AMFI's expense ratio file. Cost rank: where this plan comes when the Thematic funds' plans of the same type are sorted from the lowest total expense ratio to the highest.

Direct vs Regular: what the gap cost

Both plans own the same portfolio, so the difference in what they earned is the Regular plan's extra cost, taken out of its NAV.

Over the last	Regular	Direct	Direct earned more by	₹1 lakh became (Regular)	₹1 lakh became (Direct)
1 year	17.02%	19.00%	1.98%	₹1,17,020	₹1,19,000

Returns over more than 1 year are a rate a year (CAGR). ₹1 lakh invested once at the start of each period, valued on the last NAV.

Bajaj Finserv Healthcare Fund SIP Calculator

What a one-time or monthly investment in this fund would be worth today, from its own NAV history

Growth of an investment

Every month₹

Step up each year

PeriodFor

₹10,000 on the first trading day of every month, from 30-12-2024 to 30-10-2026: 23 instalments, ₹2,30,000 in all.

Investment	Invested	Value now	Gain	Return a year
Direct planBajaj Finserv Healthcare Fund (Direct)	₹2,30,000	₹2,74,498	₹44,498	19.0%
Regular planBajaj Finserv Healthcare Fund (Regular)	₹2,30,000	₹2,69,829	₹39,829	17.1%
BSE Healthcare TRI	₹2,30,000	₹2,61,670	₹31,670	13.6%
Category averageCategory average, 235 Thematic funds	₹2,30,000	₹2,36,889	₹6,889	3.0%

₹0₹1.0 L₹2.0 L₹3.0 L

20252026

Direct planBajaj Finserv Healthcare Fund (Direct)Regular planBajaj Finserv Healthcare Fund (Regular)BSE Healthcare TRICategory averageCategory average, 235 Thematic fundsAmount invested

From each plan's published NAV (Growth option), the benchmark's TRI and the category average, over the same days. Return a year: XIRR for a SIP, CAGR for a lumpsum, shown for a year or more. It does not include exit load, stamp duty or tax. Past returns do not promise future returns.

Bajaj Finserv Healthcare Fund Asset Allocation

Asset allocation as on 30-09-2026

What the fund holds

95.6%Equity

Asset	Fund	Category
Equity	95.6%	94.5%
Cash and others	4.4%	4.0%

Market cap of stocks

Market cap	Fund	Category
Large Cap	30.3%	45.7%
Mid Cap	28.8%	19.6%
Small Cap	36.4%	24.1%

Share of the whole fund. Category: the average of the Thematic funds that hold stocks. Groups follow AMFI's latest list, as SEBI defines them: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.

Bajaj Finserv Healthcare Fund Sector Allocation

Sector allocation of the fund's stocks as on 30-09-2026

Largest sectors

Pharmaceuticals & Biotechnology73.7%
Healthcare Services15.6%
Food Products2.2%
Consumer Durables1.9%
Chemicals & Petrochemicals1.2%
Insurance0.8%
Fertilizers & Agrochemicals0.2%

Sector changes

Sector	July 2026	August 2026	September 2026	Change
Pharmaceuticals & Biotechnology	69.2%	71.3%	73.7%	+4.5%
Healthcare Services	18.4%	17.0%	15.6%	−2.8%
Food Products	2.7%	2.3%	2.2%	−0.5%
Consumer Durables	2.0%	2.0%	1.9%	−0.1%
Chemicals & Petrochemicals	2.0%	1.2%	1.2%	−0.8%

Each sector's share of the fund at the end of each month. The five largest sectors of September 2026. Change: from July 2026 to September 2026, in % of the fund.

Bajaj Finserv Healthcare Fund Portfolio Holdings

As on 30-09-2026 · 34 holdings · from the fund house's monthly portfolio

Holdings	Sector	Weight%	1M change
Divi's Laboratories Limited	Pharmaceuticals & Biotechnology	9.75%	−6.0%
Sun Pharmaceutical Industries Limited	Pharmaceuticals & Biotechnology	8.96%	+19.1%
Piramal Pharma Limited	Pharmaceuticals & Biotechnology	6.36%	−2.0%
Rubicon Research Limited	Pharmaceuticals & Biotechnology	6.08%	0.0%
Aurobindo Pharma Limited	Pharmaceuticals & Biotechnology	6.03%	0.0%
Apollo Hospitals Enterprise Limited	Healthcare Services	5.51%	0.0%
Torrent Pharmaceuticals Limited	Pharmaceuticals & Biotechnology	4.78%	0.0%
Emcure Pharmaceuticals Limited	Pharmaceuticals & Biotechnology	4.03%	0.0%
Laurus Labs Limited	Pharmaceuticals & Biotechnology	3.91%	+60.0%
Neuland Laboratories Limited	Pharmaceuticals & Biotechnology	3.82%	0.0%
Max Healthcare Institute Limited	Healthcare Services	2.99%	0.0%
Alkem Laboratories Limited	Pharmaceuticals & Biotechnology	2.96%	New
Zydus Lifesciences Limited	Pharmaceuticals & Biotechnology	2.57%	0.0%
IPCA Laboratories Limited	Pharmaceuticals & Biotechnology	2.40%	0.0%
Fortis Healthcare Limited	Healthcare Services	2.28%	0.0%
Zydus Wellness Limited	Food Products	2.20%	0.0%
Vijaya Diagnostic Centre Limited	Healthcare Services	2.19%	0.0%
Senores Pharmaceuticals Limited	Pharmaceuticals & Biotechnology	2.08%	0.0%
Shaily Engineering Plastics Limited	Consumer Durables	1.88%	0.0%
Dr. Lal Path Labs Limited	Healthcare Services	1.73%	0.0%
GlaxoSmithKline Pharmaceuticals Limited	Pharmaceuticals & Biotechnology	1.63%	0.0%
Glenmark Pharmaceuticals Limited	Pharmaceuticals & Biotechnology	1.60%	0.0%
Dr. Reddy's Laboratories Limited	Pharmaceuticals & Biotechnology	1.37%	0.0%
Cipla Limited	Pharmaceuticals & Biotechnology	1.33%	0.0%
Bajaj Finserv Money Market Fund-Direct Plan-Growth		1.31%
Sanofi Consumer Healthcare India Limited	Pharmaceuticals & Biotechnology	1.30%	0.0%
Biocon Limited	Pharmaceuticals & Biotechnology	1.05%	0.0%
Navin Fluorine International Limited	Chemicals & Petrochemicals	0.94%	0.0%
Krishna Institute Of Medical Sciences Limited	Healthcare Services	0.92%	0.0%
Jubilant Pharmova Limited	Pharmaceuticals & Biotechnology	0.89%	0.0%
Onesource Specialty Pharma Limited	Pharmaceuticals & Biotechnology	0.83%	0.0%
Medi Assist Healthcare Services Limited	Insurance	0.75%	0.0%
Neogen Chemicals Limited	Chemicals & Petrochemicals	0.23%	0.0%
Sumitomo Chemical India Limited	Fertilizers & Agrochemicals	0.21%	0.0%

Bajaj Finserv Healthcare Fund Stocks Bought and Sold

All changes are between August 2026 and September 2026

Stocks bought and sold in September 2026

Divi's Laboratories Limited	Reduced	−6.0%	9.75%
Sun Pharmaceutical Industries Limited	Added	+19.1%	8.96%
Piramal Pharma Limited	Reduced	−2.0%	6.36%
Laurus Labs Limited	Added	+60.0%	3.91%
Alkem Laboratories Limited	New	New	2.96%
Turtlemint Fintech Solutions Limited	Sold out	−100%	was 0.92%
MTAR Technologies Limited	Sold out	−100%	was 0.26%

A change is counted by the number of shares the fund holds, not by price. A stock can become a smaller part of the fund in a month when the fund bought more of it, if its price fell. Debt papers are left out.

What Bajaj Finserv Healthcare Fund bought and sold

Bajaj Finserv Healthcare Fund Portfolio Overlap

Funds with the most similar portfolios, across every fund house and category

Fund	Overlap	Holdings in common
Mirae Asset Nifty 500 Healthcare ETFETF · Mirae Asset	60.0%	24	Compare
ITI Pharma and Healthcare FundThematic · ITI	58.7%	19	Compare
Bandhan BSE Healthcare Index FundIndex · Bandhan	56.2%	27	Compare
DSP Nifty Healthcare Index FundIndex · DSP	56.2%	16	Compare
Aditya Birla Sun Life Nifty Healthcare ETFETF · Aditya Birla Sun Life	56.2%	16	Compare
ICICI Prudential Nifty Healthcare ETFETF · ICICI Prudential	56.2%	16	Compare
Axis NIFTY Healthcare ETFETF · Axis	56.2%	16	Compare
DSP Nifty Healthcare ETFETF · DSP	56.2%	16	Compare

Overlap: for each holding both funds own, the smaller of its two weights, added up. 40% means 40% of each fund's money sits in positions the other also holds. From each fund's latest monthly portfolio, matched by ISIN. Cash and hedged positions are left out. Funds that overlap under 10% are not listed. A high overlap does not make two funds the same: their costs, lock-in and category can differ.

Bajaj Finserv Healthcare Fund Overview

Fund facts from the scheme summary document, as on 16-10-2026

Expense ratio (Direct): 0.90%
Expense ratio (Regular): 2.59%
Category: Thematic
Risk: Very High
Benchmark: BSE Healthcare TRI
Launch date: 27-12-2024
Minimum investment: ₹500
Minimum additional investment: ₹100
AUM: ₹405.14 Cr (30-09-2026)
Lock in: None
Scheme code (Direct): 153157
ISIN (Direct): INF0QA701AB9
Scheme code (Regular): 153155
ISIN (Regular): INF0QA701987
NAV history: From 30-12-2024, 1.8 years

Exit load: 1% for redemption within 3 Months

Tax on Bajaj Finserv Healthcare Fund returns

Bajaj Finserv Healthcare Fund is taxed as an equity fund: 65% or more of it is in Indian stocks.
Units sold within 1 year: the gain is taxed at 20%.
Units held longer: gains above ₹1.25 lakh in a financial year, across all your equity funds and shares, are taxed at 12.5%.
IDCW (dividend) payouts are added to your income and taxed at your slab rate.
A stamp duty of 0.005% is deducted when you invest.

Rules in force from 23-07-2024 (Finance Act 2024). Tax depends on your own income; this is general information, not tax advice.

All plans and options

Plan	Option	NAV	As on
direct	Growth	₹11.883	30-10-2026
direct	IDCW	₹11.883	30-10-2026
regular	Growth	₹11.519	30-10-2026
regular	IDCW	₹11.519	30-10-2026

About Bajaj Finserv Healthcare Fund

Bajaj Finserv Healthcare Fund is a mutual fund from Bajaj Finserv Mutual Fund. Its category is Thematic. It was launched on 27-12-2024. Its benchmark is BSE Healthcare TRI. At the end of September 2026 it held 34 securities.

Fund Manager

Bharat Hegde
Fund manager of Bajaj Finserv Healthcare Fund
Sorbh Gupta
Fund manager of Bajaj Finserv Healthcare Fund
Siddharth Chaudhary
Fund manager of Bajaj Finserv Healthcare Fund

See all funds of Bajaj Finserv Mutual Fund

AUM change

September 2026: ₹405.14 Cr; −0.19% from August 2026
August 2026: ₹405.91 Cr; +7.73% from July 2026
July 2026: ₹376.77 Cr; +6.42% from June 2026

AUM moves with money invested or taken out, and with the value of what the fund holds.

Compare Bajaj Finserv Healthcare Fund with Other Funds

Returns, risk, costs and the stocks they share, side by side

Bajaj Finserv Healthcare vs Nippon India Taiwan EquityThematic
Bajaj Finserv Healthcare vs HDFC DefenceThematic
Bajaj Finserv Healthcare vs HDFC Pharma and HealthcareThematic
Bajaj Finserv Healthcare vs SBI Healthcare OpportunitiesThematic
Bajaj Finserv Healthcare vs Aditya Birla Sun Life International EquityThematic
Bajaj Finserv Healthcare vs Mirae Asset Nifty 500 Healthcare ETF60.0% overlap
Bajaj Finserv Healthcare vs ITI Pharma and Healthcare58.7% overlap
Bajaj Finserv Healthcare vs Bandhan BSE Healthcare Index56.2% overlap

Compare with any other fund

Frequently Asked Questions for Bajaj Finserv Healthcare Fund

What is the current NAV of Bajaj Finserv Healthcare Fund?

The Direct plan NAV is ₹11.883. The Regular plan NAV is ₹11.519, as on 30-10-2026.

What are the returns of Bajaj Finserv Healthcare Fund?

The Direct plan returned +19.00% in 1 year. The Regular plan returned +17.02% in 1 year. These figures are as on 30-10-2026.

What is the expense ratio of Bajaj Finserv Healthcare Fund?

The Direct plan charges 0.90% a year. The Regular plan charges 2.59% a year. This is the figure the fund house reported to AMFI, in force from 01-09-2026.

What is the AUM of Bajaj Finserv Healthcare Fund?

Bajaj Finserv Healthcare Fund managed ₹405.14 Cr on 30-09-2026, as its fund house reported in its monthly portfolio.

What are the top holdings of Bajaj Finserv Healthcare Fund?

At the end of September 2026 the largest holdings were DIVISLAB (9.75%), SUNPHARMA (8.96%), PPLPHARMA (6.36%), RUBICON (6.08%), AUROPHARMA (6.03%). The fund held 34 securities in all.

What did Bajaj Finserv Healthcare Fund buy and sell in September 2026?

It bought 1 new stock: Alkem Laboratories Limited. It sold out of 2: Turtlemint Fintech Solutions Limited, MTAR Technologies Limited. It added shares in 2. It reduced 2.

How do I invest in Bajaj Finserv Healthcare Fund?

Through Bajaj Finserv Mutual Fund's website or app, a mutual fund distributor, or an investment platform. Choose the Direct plan to pay no distributor commission, or the Regular plan to invest through a distributor. The first investment is at least ₹500. You can invest once or through a monthly SIP.

Who is the fund manager of Bajaj Finserv Healthcare Fund?

Bharat Hegde, Sorbh Gupta, Siddharth Chaudhary.

Sources: NAV and expense ratio from AMFI. Holdings from the fund house's monthly portfolio statement. Fund facts from its scheme summary document, as on 16-10-2026.

This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.